Trial NCT01703260

View at ClinicalTrials.gov 
Org. Study IDs: ROF-NASH_205
Secondary IDs: U1111-1129-5051

Last trial update was posted on 2017-02-01

MeSH Interventions

Pioglitazone

MeSH Conditions

Fatty Liver Non-alcoholic Fatty Liver Disease

Other Conditions

Nonalcoholic Steatohapatitis

Stopping Reasons

Company decision; No safety or efficacy concerns (see detailed description)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID